# Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rates-of-initial-and-recurrent-thromboembolic-disease-among-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Nathan Levitan,Afshin Dowlati,Scot C. Remick,Hassan I. Tahsildar,Lynn D. Sivinski,Rebecca J. Beyth,Alfred A. Rimm |
| Citations | 894 |
| DOI | 10.1097/00005792-199909000-00001 |
| Fields | Health Professions,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2313284959 |
| PMID | 10499070 |
| Type | article |
| Year | 1999 |

## Paper authors

- [Afshin Dowlati](https://scholariq.org/researchers/afshin-dowlati/)

## Paper journal

- [Medicine](https://scholariq.org/journals/medicine/)

## Paper primary topic

- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)

## Paper topics

- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Central Venous Catheters and Hemodialysis](https://scholariq.org/topics/central-venous-catheters-and-hemodialysis/)
- [Chemotherapy-induced cardiotoxicity and mitigation](https://scholariq.org/topics/chemotherapy-induced-cardiotoxicity-and-mitigation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.